rs41286572

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000699461.1(MEG9):​n.382-1649G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0657 in 534,412 control chromosomes in the GnomAD database, including 1,381 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.061 ( 342 hom., cov: 32)
Exomes 𝑓: 0.068 ( 1039 hom. )

Consequence

MEG9
ENST00000699461.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0710

Publications

8 publications found
Variant links:
Genes affected
MEG9 (HGNC:43874): (maternally expressed 9)
MIR154 (HGNC:31541): (microRNA 154) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0751 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR154NR_029704.1 linkn.*6G>A downstream_gene_variant
MIR154unassigned_transcript_2437 n.*54G>A downstream_gene_variant
MIR154unassigned_transcript_2438 n.*18G>A downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEG9ENST00000699461.1 linkn.382-1649G>A intron_variant Intron 3 of 6
MIR154ENST00000385243.1 linkn.*6G>A downstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.0611
AC:
9289
AN:
152124
Hom.:
341
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0276
Gnomad AMI
AF:
0.189
Gnomad AMR
AF:
0.0587
Gnomad ASJ
AF:
0.0626
Gnomad EAS
AF:
0.0297
Gnomad SAS
AF:
0.0548
Gnomad FIN
AF:
0.0990
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0769
Gnomad OTH
AF:
0.0670
GnomAD2 exomes
AF:
0.0628
AC:
15742
AN:
250856
AF XY:
0.0640
show subpopulations
Gnomad AFR exome
AF:
0.0265
Gnomad AMR exome
AF:
0.0328
Gnomad ASJ exome
AF:
0.0558
Gnomad EAS exome
AF:
0.0303
Gnomad FIN exome
AF:
0.100
Gnomad NFE exome
AF:
0.0776
Gnomad OTH exome
AF:
0.0649
GnomAD4 exome
AF:
0.0676
AC:
25818
AN:
382170
Hom.:
1039
Cov.:
0
AF XY:
0.0677
AC XY:
14730
AN XY:
217556
show subpopulations
African (AFR)
AF:
0.0274
AC:
288
AN:
10508
American (AMR)
AF:
0.0326
AC:
1184
AN:
36292
Ashkenazi Jewish (ASJ)
AF:
0.0555
AC:
651
AN:
11724
East Asian (EAS)
AF:
0.0310
AC:
408
AN:
13172
South Asian (SAS)
AF:
0.0558
AC:
3722
AN:
66724
European-Finnish (FIN)
AF:
0.0992
AC:
3206
AN:
32304
Middle Eastern (MID)
AF:
0.0862
AC:
242
AN:
2806
European-Non Finnish (NFE)
AF:
0.0778
AC:
14936
AN:
191928
Other (OTH)
AF:
0.0707
AC:
1181
AN:
16712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1432
2863
4295
5726
7158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0610
AC:
9290
AN:
152242
Hom.:
342
Cov.:
32
AF XY:
0.0614
AC XY:
4567
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0276
AC:
1147
AN:
41562
American (AMR)
AF:
0.0586
AC:
896
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0626
AC:
217
AN:
3468
East Asian (EAS)
AF:
0.0297
AC:
154
AN:
5178
South Asian (SAS)
AF:
0.0553
AC:
266
AN:
4814
European-Finnish (FIN)
AF:
0.0990
AC:
1049
AN:
10592
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0768
AC:
5227
AN:
68018
Other (OTH)
AF:
0.0653
AC:
138
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
449
897
1346
1794
2243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0603
Hom.:
157
Bravo
AF:
0.0554
Asia WGS
AF:
0.0470
AC:
163
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
14
DANN
Benign
0.90
PhyloP100
-0.071

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41286572; hg19: chr14-101526181; COSMIC: COSV62998895; API